CClinicalTrials.gg
Sign In
Status unknownNCT02099422TOPICUpdated Mar 28, 2014

Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

An observational study in Acute Coronary Syndrome, Coronary Stenting and Antiplatelet Therapy, sponsored by Hôpital de la Timone. Status unknown at 1 site in France. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2014-03-28.

Sponsored by Hôpital de la Timone · Observational

The sponsor has not verified this record recently (last verified Mar 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
500
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Comparison of two antiplatelet strategies between months 1 and 12 after coronary stenting for ACS. Efficiency and tolerance évaluation

02

Conditions studied

  • Acute Coronary Syndrome
  • Coronary Stenting
  • Antiplatelet Therapy
03

In context

Acute Coronary Syndrome

1,461 studies on the registry are indexed under Acute Coronary Syndrome; 267 are open to participants now.

This study's planned enrollment of 500 is close to the median of 500 across 561 observational studies indexed under Acute Coronary Syndrome.

Browse Acute Coronary Syndrome studies →

Lead sponsor

Hôpital de la Timone is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients with ACS treated by coronary stent implantation

Inclusion criteria

  • ACS and coronary stenting one month ago

Exclusion criteria

Exclusion Criteria:

  • age under 18 and pregnancy
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. combined ischemic and hemorragic endpoint

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • CHU Timone hospital . Sc CARDIOLOGIE. Rue saint Pierre.
    Marseille, 13005, France
    • thomas cuisset, MD-PHD · Contact · thomas.cuisset@ap-hm.fr · 33(0)491385981
    • thomas cuisset, MD-PHD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02099422
Lead sponsor
Hôpital de la Timone
Responsible party
CUISSET Thomas (MD-PHD, Hôpital de la Timone) — Principal investigator
First posted
Mar 28, 2014
Start date
Jan 2013
Primary completion
Jan 2015 (estimated)
Completion
Jan 2016 (estimated)
Last update
Mar 28, 2014

Study contacts

thomas cuisset, MD-PHD
Contact
thomas.cuisset@ap-hm.fr
33(0) 491385981

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Acute Coronary Syndrome→

Other studies from this sponsor

Hôpital de la Timone

Start the discussion